Can adverse cardiac events of the COVID-19 vaccine exacerbate preexisting diseases?

References

• Andre FE, Booy R, Bock HL, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ. 2008;86(2):140–146. doi: 10.2471/BLT.07.040089
   PubMed Web of Science ®Google Scholar
• Majumder MAA, Lutfor AB, Rabbi AMF, et al. Prevalence of COVID-19 vaccine reactogenicity among Bangladeshi physicians. FASEB Bioadv. 2022;4(6):379–390. doi: 10.1096/fba.2021-00158
   PubMedGoogle Scholar
• Majumder MAA, Singh K, Johnson WMS, et al. Evaluation of short-term side effects following the first dose of COVID-19 vaccines among physicians and dentists: a cross-sectional study from India. J Multidiscip Healthc. 2023;16:161–174. doi: 10.2147/JMDH.S390364. eCollection 2023
   PubMed Web of Science ®Google Scholar
• Razzaque MS, Jaser SKK, Prado RCR, et al. Commentaries on viewpoint: COVID-19 controls causing a kerfuffle. J Appl Physiol. 2022;133:1222–1225. doi: 10.1152/japplphysiol.00536.2022
   PubMed Web of Science ®Google Scholar
• Azim Majumder MA, Razzaque MS. Repeated vaccination and ‘vaccine exhaustion’: relevance to the COVID-19 crisis. Expert Rev Vaccines. 2022;21(8):1011–1014. doi: 10.1080/14760584.2022.2071705
   PubMed Web of Science ®Google Scholar
• Alam A, Azim Majumder MA, Haque M, et al. Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh. Expert Rev Vaccines. 2021;20(9):1167–1175. doi: 10.1080/14760584.2021.1951248.
   PubMed Web of Science ®Google Scholar
• Jeet Kaur R, Dutta S, Charan J, et al. Cardiovascular adverse events reported from COVID-19 vaccines: a study based on WHO database. Int J Gen Med. 2021;14:3909–3927. doi: 10.2147/IJGM.S324349
   PubMedGoogle Scholar
• Linschoten M, Peters S, van Smeden M, et al. Cardiac complications in patients hospitalised with COVID-19. Eur Heart J Acute Cardiovasc Care. 2020;9(8):817–823. doi: 10.1177/2048872620974605
   PubMed Web of Science ®Google Scholar
• Daniels CJ, Rajpal S, Greenshields JT, et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 2021;6(9):1078–1087. doi: 10.1001/jamacardio.2021.2065
   PubMed Web of Science ®Google Scholar
• Annie FH, Alkhaimy H, Nanjundappa A, et al. Association between myocarditis and mortality in COVID-19 patients in a large registry. Mayo Clin Proc Innov Qual Outcomes. 2022;6(2):114–119. doi: 10.1016/j.mayocpiqo.2021.12.006.
   PubMedGoogle Scholar
• Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265–1273. doi: 10.1001/jamacardio.2020.3557
   PubMed Web of Science ®Google Scholar
• Lindner D, Fitzek A, Bräuninger H, et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 2020;5:1281–1285. doi: 10.1001/jamacardio.2020.3551
   PubMed Web of Science ®Google Scholar
• Rout A, Suri S, Vorla M, et al. Myocarditis associated with COVID-19 and its vaccines - a systematic review. Prog Cardiovasc Dis. 2022;74:111–121. doi: 10.1016/j.pcad.2022.10.004
   PubMed Web of Science ®Google Scholar
• Razzaque MS. Healthcare-associated infections in the context of the pandemic. Front Health Serv. 2023;3:1288033. doi: 10.3389/frhs.2023.1288033
   PubMedGoogle Scholar
• Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021;144(6):471–484. doi: 10.1161/CIRCULATIONAHA.121.056135
   PubMed Web of Science ®Google Scholar
• Abu Mouch S, Roguin A, Hellou E, et al. Myocarditis following COVID-19 mRNA vaccination. Vaccine. 2021;39(29):3790–3793. doi: 10.1016/j.vaccine.2021.05.087
   PubMed Web of Science ®Google Scholar
• D’Angelo T, Cattafi A, Carerj ML, et al. Myocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction? Can J Cardiol. 2021;37(10):1665–1667. doi: 10.1016/j.cjca.2021.05.010
   PubMed Web of Science ®Google Scholar
• Su JR, McNeil MM, Welsh KJ, et al. Myopericarditis after vaccination, vaccine adverse event reporting system (VAERS), 1990–2018. Vaccine. 2021;39(5):839–845. doi: 10.1016/j.vaccine.2020.12.046
   PubMed Web of Science ®Google Scholar
• Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385(12):1078–1090. doi: 10.1056/NEJMoa2110475
   PubMed Web of Science ®Google Scholar
• Patone M, Mei XW, Handunnetthi L, et al. Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex. Circulation. 2022;146(10):743–754. doi: 10.1161/CIRCULATIONAHA.122.059970
   PubMed Web of Science ®Google Scholar
• Patone M, Mei XW, Handunnetthi L, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. 2022;28(2):410–422. doi: 10.1038/s41591-021-01630-0
   PubMed Web of Science ®Google Scholar
• Thurner L, Kessel C, Fadle N, et al. IL-1RA antibodies in myocarditis after SARS-CoV-2 vaccination. N Engl J Med. 2022;387(16):1524–1527. doi: 10.1056/NEJMc2205667
   PubMed Web of Science ®Google Scholar
• Chen CY, Hsieh MT, Wei CT, et al. Atrial fibrillation after mRNA-1273 SARS-CoV-2 vaccination: case report with literature review. Risk Manag Healthc Policy. 2023;16:209–214. doi: 10.2147/RMHP.S402007
   PubMed Web of Science ®Google Scholar
• Musikantow DR, Turagam MK, Sartori S, et al. Atrial fibrillation in patients hospitalized with COVID-19: incidence, predictors, outcomes, and comparison to influenza. JACC Clin Electrophysiol. 2021;7(9):1120–1130. doi: 10.1016/j.jacep.2021.02.009.
   PubMedGoogle Scholar
• Rosenblatt AG, Ayers CR, Rao A, et al. New-onset atrial fibrillation in patients hospitalized with COVID-19: results from the American heart association COVID-19 cardiovascular registry. Circ Arrhythm Electrophysiol. 2022;15(5):e010666. doi: 10.1161/CIRCEP.121.010666
   PubMed Web of Science ®Google Scholar
• Colon CM, Barrios JG, Chiles JW, et al. Atrial arrhythmias in COVID-19 patients. JACC Clin Electrophysiol. 2020;6(9):1189–1190. doi: 10.1016/j.jacep.2020.05.015
   PubMedGoogle Scholar
• Peltzer B, Manocha KK, Ying X, et al. Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19. J Cardiovasc Electrophysiol. 2020;31(12):3077–3085. doi: 10.1111/jce.14770
   PubMed Web of Science ®Google Scholar
• Kumar A, Shariff M, Bhat V, et al. Atrial fibrillation after vaccination for COVID-19: analysis of the vaccine adverse event reporting system. J Interv Card Electrophysiol. 2022;65(1):1–2. doi: 10.1007/s10840-022-01263-4
   PubMed Web of Science ®Google Scholar
• Boyko EJ. Observational research — opportunities and limitations. J Diabetes Complications. 2013;27(6):642–648. doi: 10.1016/j.jdiacomp.2013.07.007
   PubMed Web of Science ®Google Scholar
• Gilmartin-Thomas JF, Liew D, Hopper I. Observational studies and their utility for practice. Aust Prescr. 2018;41(3):82–85. doi: 10.18773/austprescr.2018.017
   PubMedGoogle Scholar
• Saad M, Kennedy KF, Imran H, et al. Association between COVID-19 diagnosis and in-hospital mortality in patients hospitalized with ST-Segment elevation myocardial infarction. JAMA. 2021;326(19):1940–1952. doi: 10.1001/jama.2021.18890
   PubMed Web of Science ®Google Scholar
• Ho FK, Man KKC, Toshner M, et al. Thromboembolic risk in hospitalized and nonhospitalized COVID-19 patients: a self-controlled case series analysis of a nationwide cohort. Mayo Clin Proc. 2021;96(10):2587–2597. doi: 10.1016/j.mayocp.2021.07.002
   PubMed Web of Science ®Google Scholar
• Toscano O, Cosentino N, Campodonico J, et al. Acute myocardial infarction during the COVID-19 pandemic: an update on clinical characteristics and outcomes. Front Cardiovasc Med. 2021;8:648290. doi: 10.3389/fcvm.2021.648290
   PubMedGoogle Scholar
• Baqi DH, Kakamad FH, Mahmood ZH, et al. Myocardial infarction following COVID-19 vaccine administration; a systematic review. Heliyon. 2022;8(11):e11385. doi: 10.1016/j.heliyon.2022.e11385
   PubMed Web of Science ®Google Scholar
• Aye YN, Mai AS, Zhang A, et al. Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM. 2023;116(4):279–283. doi: 10.1093/qjmed/hcab252
   PubMed Web of Science ®Google Scholar
• Ou W, Wang B, Zhang G, et al. Acute myocardial infarction after inactivated COVID-19 vaccination: a case report and literature review. Front Cardiovasc Med. 2023;10:1123385. doi: 10.3389/fcvm.2023.1123385
   PubMedGoogle Scholar
• Zhang J, Wu J, Sun X, et al. Association of hypertension with the severity and fatality of SARS-CoV-2 infection: a meta-analysis. Epidemiol Infect. 2020;148:e106. doi: 10.1017/S095026882000117X
   PubMed Web of Science ®Google Scholar
• Akpek M. Does COVID-19 cause hypertension? Angiology. 2022;73(7):682–687. doi: 10.1177/00033197211053903
   PubMed Web of Science ®Google Scholar
• Chen G, Li X, Gong Z, et al. Hypertension as a sequela in patients of SARS-CoV-2 infection. PLoS One. 2021;16(4):e0250815. doi: 10.1371/journal.pone.0250815
   PubMed Web of Science ®Google Scholar
• Badaró R, Novaes G, Andrade AC, et al. Myocardial infarction or myocarditis? A case report and review of a myocardial adverse event associated with mRNA vaccine. Front Med. 2023;10:1071239. doi: 10.3389/fmed.2023.1071239
   Web of Science ®Google Scholar
• Angeli F, Zappa M, Oliva FM, et al. Blood pressure increase during hospitalization for COVID-19. Eur J Intern Med. 2022;104:110–112. doi: 10.1016/j.ejim.2022.06.010
   PubMed Web of Science ®Google Scholar
• Bazdyrev E, Panova M, Zherebtsova V, et al. The hidden pandemic of COVID-19-Induced organizing pneumonia. Pharmaceuticals (Basel). 2022;15(12):1574. doi: 10.3390/ph15121574
   PubMedGoogle Scholar
• Halawa S, Pullamsetti SS, Bangham CRM, et al. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective. Nat Rev Cardiol. 2022;19(5):314–331. doi: 10.1038/s41569-021-00640-2
   PubMed Web of Science ®Google Scholar
• Zhang P, Zhu L, Cai J, et al. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. 2020;126(12):1671–1681. doi: 10.1161/CIRCRESAHA.120.317134
   PubMed Web of Science ®Google Scholar
• Meylan S, Livio F, Foerster M, et al. Stage III hypertension in patients after mRNA-based SARS-CoV-2 vaccination. Hypertension. 2021;77(6):e56–e57. doi: 10.1161/HYPERTENSIONAHA.121.17316
   PubMed Web of Science ®Google Scholar
• Angeli F, Reboldi G, Trapasso M, et al. Blood pressure increase following COVID-19 vaccination: a systematic overview and meta-analysis. J Cardiovasc Dev Dis. 2022;9(5):150. doi: 10.3390/jcdd9050150
   PubMed Web of Science ®Google Scholar
• Syrigos N, Kollias A, Grapsa D, et al. Significant increase in blood pressure following BNT162b2 mRNA COVID-19 vaccination among healthcare workers: a rare event. Vaccines. 2022;10(5):745. doi: 10.3390/vaccines10050745
   Web of Science ®Google Scholar
• Zappa M, Verdecchia P, Spanevello A, et al. Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine. Eur J Intern Med. 2021;90:111–113. doi: 10.1016/j.ejim.2021.06.013
   PubMed Web of Science ®Google Scholar
• Buso G, Agabiti-Rosei C, Muiesan ML. The relationship between COVID-19 vaccines and increased blood pressure: a word of caution. Eur J Intern Med. 2023;111:27–29. doi: 10.1016/j.ejim.2023.03.002
   PubMed Web of Science ®Google Scholar
• Pasha AK, McBane RD, Chaudhary R, et al. Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19. Thromb Res. 2021;207:150–157. doi: 10.1016/j.thromres.2021.09.021
   PubMed Web of Science ®Google Scholar
• MacNeil JR, Su JR, Broder KR, et al. Updated recommendations from the advisory committee on immunization practices for use of the Janssen (Johnson & Johnson) COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome among vaccine recipients — United States, April 2021. MMWR Morb Mortal Wkly Rep. 2021;70(17):651–656. doi: 10.15585/mmwr.mm7017e4
   PubMed Web of Science ®Google Scholar
• Lopes LA, Agrawal DK. Thromboembolism in the complications of long COVID-19. Cardiol Cardiovasc Med. 2023;7(2):123–128. doi: 10.26502/fccm.92920317
   PubMedGoogle Scholar
• Porfidia A, Valeriani E, Pola R, et al. Venous thromboembolism in patients with COVID-19: systematic review and meta-analysis. Thromb Res. 2020;196:67–74. doi: 10.1016/j.thromres.2020.08.020
   PubMed Web of Science ®Google Scholar
• Gąsecka A, Borovac JA, Guerreiro RA, et al. Thrombotic complications in patients with COVID-19: pathophysiological mechanisms, diagnosis, and treatment. Cardiovasc Drugs Ther. 2021;35(2):215–229. doi: 10.1007/s10557-020-07084-9
   PubMed Web of Science ®Google Scholar
• Fanaroff AC, Lopes RD. COVID-19 thrombotic complications and therapeutic strategies. Annu Rev Med. 2023;74(1):15–30. doi: 10.1146/annurev-med-042921-110257
   PubMedGoogle Scholar
• Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384(22):2092–2101. doi: 10.1056/NEJMoa2104840
   PubMed Web of Science ®Google Scholar
• Li X, Burn E, Duarte-Salles T, et al. Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different COVID-19 vaccines: international network cohort study from five European countries and the US. BMJ. 2022;379:e071594. doi: 10.1136/bmj-2022-071594
   PubMedGoogle Scholar
• Sánchez van Kammen M, AguiardeSousa D, Poli S, et al. Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia. JAMA Neurol. 2021;78(11):1314–1323. doi: 10.1001/jamaneurol.2021.3619.
   PubMed Web of Science ®Google Scholar
• Scully M, Singh D, Lown R, et al. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021;384(23):2202–2211. doi: 10.1056/NEJMoa2105385
   PubMed Web of Science ®Google Scholar
• Houghton DE, Wysokinski W, Casanegra AI, et al. Risk of venous thromboembolism after COVID-19 vaccination. J Thromb Haemost. 2022;20(7):1638–1644. doi: 10.1111/jth.15725
   PubMed Web of Science ®Google Scholar
• Lassen MCH, Modin D, Skaarup KG, et al. Risk of incident thromboembolic and ischemic events after COVID-19 vaccination compared with SARS-CoV-2 infection. Circulation. 2023;147(10):843–845. doi: 10.1161/CIRCULATIONAHA.122.063296
   PubMed Web of Science ®Google Scholar
• Ye X, Yan VKC, Yiu HHE, et al. BNT162b2 or coronavac vaccinations are associated with a lower risk of myocardial infarction and stroke after SARS-CoV-2 infection among patients with cardiovascular disease. J Am Heart Assoc. 2023;12(9):e029291. doi: 10.1161/JAHA.122.029291
   PubMed Web of Science ®Google Scholar
• Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun. 2022;103:154–162. doi: 10.1016/j.bbi.2022.04.013
   PubMed Web of Science ®Google Scholar
• Saeed S, Tadic M, Larsen TH, et al. Coronavirus disease 2019 and cardiovascular complications: focused clinical review. J Hypertens. 2021;39(7):1282–1292. doi: 10.1097/HJH.0000000000002819
   PubMed Web of Science ®Google Scholar